Teva Pays $27M To End Antipsychotic Drug Kickback Claims

Law360, New York (March 11, 2014, 2:35 PM EDT) -- Teva Pharmaceuticals USA Inc. will pay the U.S. Department of Justice and the state of Illinois $27.6 million for allegedly paying a doctor to push prescriptions of a risky antipsychotic drug used to treat schizophrenia to patients, the DOJ announced Tuesday.

The North Wales, Pa.-based drug company and a subsidiary, Ivax LLC, admitted no wrongdoing as part of the deal to settle the government's claims, which included accusations that it provided Illinois physician Dr. Michael J. Reinstein with $50,000 per year and other benefits to prescribe...
To view the full article, register now.